Moderna shares plunge after company cuts vaccine sales outlook
The Cambridge-based company said it expects 2025 revenue of between $1.5 billion to $2.5 billion, down from its previous ...
Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting ...
Moderna surprises the Street by predicting a bigger-than-expected sales drop
Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year.
Moderna cuts sales forecast on weaker vaccine demand
Moderna ( MRNA) cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine.
Investor's Business Daily on MSN40m
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting ...
Moderna shares slide after sales guidance slashed
Moderna shares dropped as much as 22 per cent on Monday after the US biotech group’s sales forecasts disappointed investors.
These Stocks Are Moving the Most Today: Nvidia, Micron, Moderna, Intra-Cellular Therapies, D-Wave Quantum, Edison, U.S. Steel, and More
Nvidia pushes back on new artificial-intelligence regulations, Moderna issues weak revenue guidance, and Intra-Cellular ...